- Fever
- Pain
- Patent Ductus Arteriosus
- Others
Paracetamol Infusion Market was valued at USD 699.1 million in 2022 and is expanded to grow at a significant CAGR of 3.86% over 2023-2029. The increased application of paracetamol as a first-line pain and fever reliever propels the global paracetamol infusion market forward. The National Health Service (NHS), The National Institute for Health and Care Excellence (NICE), and the Centers for Disease Control and Prevention (CDC) have all advised paracetamol because of its broad availability. Initially, the COVID-19 pandemic created a rise in market for over-the-counter medicines like paracetamol, causing local authorities to place export limits on key drugs while maintaining acceptable supply levels in their country. Likewise, the drug's broad use in COVID-19-affected patients to control various symptoms of cold, cough, and fever is projected to boost market expansion. Furthermore, supportive government policies and schemes such as Pharma Vision 2020, the construction of bulk drug parks, and the production linked incentive programme for domestic bulk drug production are likely to generate attractive chances for market growth in the coming years. People suffering from high fevers and aches and pains linked with the flu frequently take paracetamol. Influenza is a problem in tropical areas. The market is growing due to the rising burden of symptomatic conditions and the usage of OTC medications. Following COVID-19, the Indian chemists' association has agreed not to dispense cold, cough, and fever drugs to anyone without a prescription. However, following the epidemic, local market players expanded paracetamol manufacturing and attempts to encourage availability. Amid the pandemic, increased paracetamol production by local market players, as well as steps to stimulate availability, is projected to drive segment growth throughout the forecast period. The application fever and pain segment is expected to hold the most significant market share in the forecasting years. The rising prevalence of pain and fever is expected the drive this segment. Moreover, COVID-19 has led to a positive impact on the global paracetamol infusion market.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The rising prevalence of conditions like headaches, flu etc. and the increasing demand for pain management drugs are the major growth drivers for the paracetamol infusion market. Paracetamol is widely used in treatment of mild to moderate pains, including headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches, and pains. Furthermore, it is an effective antipyretic used to reduce fever. However, the side effects associated with the use of paracetamol may hamper the market. Common side effects of paracetamol includes rash, itching, difficulty breathing or swelling of face, lips, throat or tongue.
The paracetamol infusion market is projected to expand at a CAGR of 3.86% during the forecast period
Altan Pharma Ltd., Abbott, Inc., Cipla Ltd., B. Braun Melsungen AG, Pfizer, Inc., Intas Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Ipca Laboratories Ltd., Sun Pharmaceutical Industries, Ltd., Biocon Limited
North American is the fastest-growing region for paracetamol infusion market
1.Executive Summary |
2.Global Paracetamol Infusion Market Introduction |
2.1.Global Paracetamol Infusion Market - Taxonomy |
2.2.Global Paracetamol Infusion Market - Definitions |
2.2.1.Application |
2.2.2.Region |
3.Global Paracetamol Infusion Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Paracetamol Infusion Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Paracetamol Infusion Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Fever |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Pain |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Patent Ductus Arteriosus |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Paracetamol Infusion Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. North America |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Europe |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Asia Pacific (APAC) |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Middle East and Africa (MEA) |
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Latin America |
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.North America Paracetamol Infusion Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.1.1.Fever |
7.1.2.Pain |
7.1.3.Patent Ductus Arteriosus |
7.1.4.Others |
7.2. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.2.1.United States of America (USA) |
7.2.2.Canada |
8.Europe Paracetamol Infusion Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Fever |
8.1.2.Pain |
8.1.3.Patent Ductus Arteriosus |
8.1.4.Others |
8.2. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Germany |
8.2.2.France |
8.2.3.Italy |
8.2.4.United Kingdom (UK) |
8.2.5.Spain |
8.2.6.Rest of EU |
8.2.7. |
9.Asia Pacific (APAC) Paracetamol Infusion Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Fever |
9.1.2.Pain |
9.1.3.Patent Ductus Arteriosus |
9.1.4.Others |
9.2. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.China |
9.2.2.India |
9.2.3.Australia and New Zealand (ANZ) |
9.2.4.Japan |
9.2.5.Rest of APAC |
10.Middle East and Africa (MEA) Paracetamol Infusion Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Fever |
10.1.2.Pain |
10.1.3.Patent Ductus Arteriosus |
10.1.4.Others |
10.2. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.GCC Countries |
10.2.2.South Africa |
10.2.3.Rest of MEA |
11.Latin America Paracetamol Infusion Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Fever |
11.1.2.Pain |
11.1.3.Patent Ductus Arteriosus |
11.1.4.Others |
11.2. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Brazil |
11.2.2.Mexico |
11.2.3.Rest of LA |
12. Competition Landscape |
12.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
12.2.1.Altan Pharma Limited |
12.2.2.Unital Pharmaceuticals |
12.2.3.Stellar- Bio Labs |
12.2.4.Sun Pharma |
12.2.5.Novartis |
12.2.6.Cipla |
12.2.7.Pfizer |
12.2.8.Amgen, Inc |
13. Research Methodology |
14. Appendix and Abbreviations |